Cutaneous Leishmaniasis in Saudi Arabia ascii text image
Iraqi Chemical Gear Taken from Khafji Battlefield ascii text image
Fielding of Convulsant Antidote Nerve Agent ascii text image
USCENTCOM Medical CONOPS for Desert Shield ascii text image
Summarize Medical Defense Against Chemical (CW) and Biological Warfare (BW) in Support of Operation Desert Shield ascii text image
Change in Guidance for Malaria Chemorrophylaxsis for U.S. Forces in Iraq ascii text image
Preventive Medicine Guidance for Operation Desert Shield ascii text image
Doctrine for Use of Chemical Warfare Agent Topical Skin Protectant ascii text image
Medical Support in SWA Number 7 ascii text image
Use of Pyridostigmine Bromide - Operation Desert Shield ascii text image
Nerve Agent Pyridostigmine Pretreatment ascii text image
NBC Defensive Capability ascii text image
Meeting Notes, 23 Aug 90, Subject: US Army Medical Research and Development Command Update ascii text image
Medical Chemical Update ascii text image
USCENTCOM Policy on US Forces Use of Diazepam ascii text image
Pyridostigmine Tablets ascii text image
Revision of NBC Protective Equipment Requirement in Riyadh ascii text image
Hydrogen Sulfide ascii text image
Biological Sample Collection and Processing ascii text image
ARCENT Support of Blood Transshipment Center ascii text image
Medical Chemical Update-Initiate Nerve Agent Pyridostigmine Pretreatment ascii text image
Update on Threat to Coalition Forces and Civilians from Burning Oil Wells in Kuwait ascii text image
Answers to Questions Posed Regarding Dangers Associated with Hydrogen Sulfide ascii text image
DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101
Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing.